EP-1214: Clinical outcomes of definitive chemoradiotherapy using Carboplatin and Paclitaxel in esophageal cancer
نویسندگان
چکیده
منابع مشابه
A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.
BACKGROUND In esophageal cancer (EC) patients who are not eligible for surgery, definitive chemoradiation (dCRT) with curative intent using cisplatinum with 5-fluorouracil (5-FU) is the standard chemotherapy regimen. Nowadays carboplatin/paclitaxel is also often used. In this study, we compared survival and toxicity rates between both regimens. PATIENTS AND METHODS This multicenter study incl...
متن کاملTreatment outcomes of definitive chemoradiotherapy for patients with hypopharyngeal cancer
We analyzed the efficacy of definitive chemoradiotherapy (CRT) for patients with hypopharyngeal cancer (HPC). Subjects comprised 97 patients who were treated with definitive CRT from 1990 to 2006. Sixty-one patients (62.9%) with resectable disease who aimed to preserve the larynx received induction chemotherapy (ICT), whereas 36 patients (37.1%) with resectable disease who refused an operation ...
متن کاملLong-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method
Chemoradiation therapy is widely used to treat both inoperable and operable patients, and is less invasive than surgery. Although the number of long-term survivors who have received chemoradiation therapy is increasing, the long-term toxicity pattern and cumulative incidence of toxicity regarding this modality are poorly understood. Classically, chemoradiation therapy for esophageal cancer cons...
متن کاملConcurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer
OBJECTIVE This study aimed at assessing the efficiency and safety of concurrent chemoradiotherapy (CCRT) using paclitaxel (PTX) plus cisplatin (CDDP) in elderly (age ≥70 years) esophageal cancer patients. PATIENTS AND METHODS Between July 2008 and June 2011, 82 esophageal cancer patients aged ≥70 years were retrospectively analyzed. Chemotherapy consisted of CDDP for 3 days plus PTX given for...
متن کاملSurvival Outcomes and Toxicity of Concurrent Chemoradiotherapy for Esophageal Cancer
Aims: The aim of the study was to investigate the impact of chemoradiotherapy(CRT) on survival of patients with unresectable esophageal cancer treated with radiotherapy combined with either concurrent DCF [docetaxel, cisplatin +5-fluorouracil(5-FU)] or CF [cisplatin and 5-FU).Patients and methods:Data of patients who underwent CRT for esophageal cancer during 2010 and 2015 in the department of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2015
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(15)41206-x